Summary
The stock has recorded a trading volume of 96,077 shares,. Its Average Traded Price (ATP) is ₹1706.31, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1659.20.
Tatva Chintan Pharma Chem has an upper circuit limit of ₹1988.60 and a lower circuit limit of ₹1325.80. The total value traded stands at ₹16.39 CR, and the delivery percentage for the day is 35.34%.
The stock is currently traded with a market lot size of 1. Tatva Chintan Pharma Chem also offers a dividend yield of 0.12%.
Tatva Chintan Pharma Chem Share Price Chart
Tatva Chintan Pharma Chem Share Key Metrics
Volume
96077.00
Market Cap
3881.21 CR
LTQ@LTP
2@1659.20
ATP
1706.31
Var Margin
100 %
Circuit Range
1325.8-1988.6
Delivery %
35.34 %
Value
16.39 CR
ASM/GSM
No
Market Lot
1
Tatva Chintan Pharma Chem Resistance and Support
Pivot 1686.5
Resistance
First Resistance
1722.7
Second Resistance
1786.2
Third Resistance
1822.4
Support
First Support
1623
Second Support
1586.8
Third Support
1523.3
Tatva Chintan Pharma Chem Shareholding Pattern
View More- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Tatva Chintan Pharma Chem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-17 | Quarterly Results |
| 2026-05-16 | Audited Results & Final Dividend |
| 2026-01-21 | Quarterly Results |
| 2025-10-31 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
| 2025-05-02 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-11 | 2026-09-11 | View More |
Tatva Chintan Pharma Chem News
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Credit Rating
Tatva Chintan Pharma Chem Ltd received an upgrade in its credit ratings from CRISIL. The long-term rating moved from 'CRISIL BBB+/Stable' to 'CRISIL A-/Stable', and the short-term rating from 'CRISIL A2' to 'CRISIL A2+'. This upgrade applies to bank loan facilities totaling Rs. 245 crore.
Sep 08 2026 17:17:38
Tatva Chintan Pharma Chem Ltd - 543321 - Intimation Of Record Date, Book Closure And Cut-Off Date Pursuant To Regulation 42 And 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
Tatva Chintan Pharma declared September 11, 2026, as the record date for its final dividend for FY2025-26. The dividend will be paid on or after October 01, 2026, to eligible shareholders.
Aug 27 2026 15:04:50
Tatva Chintan Pharma Chem Ltd - 543321 - Business Responsibility and Sustainability Reporting (BRSR)
Tatva Chintan Pharma Ltd filed its Business Responsibility and Sustainability Report (BRSR) for FY25-26, adhering to SEBI Listing Regulations. The report details the company's environmental, social, and governance (ESG) performance, showcasing strong compliance, zero penalties, and various green initiatives.
Aug 27 2026 14:55:06
Tatva Chintan Pharma Chem Management
| Name | Position |
|---|---|
| Ishwar Nayi | Company Secretary & Compliance Officer |
| Chintan Nitinkumar Shah | Chairman & Managing Director |
Tatva Chintan Pharma Chem Similar Stocks
Foseco India Ltd.
6194.00
0.00 (0.00%)
Responsive Industries Ltd.
169.54
0.00 (0.00%)
Dhanuka Agritech Ltd.
979.70
0.00 (0.00%)
Rallis India Ltd.
203.06
0.00 (0.00%)
GHCL Ltd.
424.70
0.00 (0.00%)
NACL Industries Ltd.
159.49
0.00 (0.00%)
Kingfa Science & Technology (India) Ltd.
6227.50
0.00 (0.00%)
Styrenix Performance Materials Ltd.
2142.90
0.00 (0.00%)
Tatva Chintan Pharma Chem FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in TATVA
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC